People with multiple sclerosis (MS) may receive less frequent treatments with anti-CD20 therapies without increasing their risk of disease activity or disability progression. That’s according to a new meta-analysis of […]
The post In MS, less frequent treatment dosing schedule is equally effective appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com